JWCA has advised Ionis Pharmaceuticals on capital market transactions with over $3.1 Billion in transaction value

November 2025: JWCA advises Ionis Pharmaceuticals on its $770 million convertible bond issuance and re-financing of outstanding convertible notes

June 2023: JWCA advises Ionis Pharmaceuticals on its $575 million convertible bond issuance and re-financing of outstanding convertible notes

April 2021: JWCA advises Ionis Pharmaceuticals on its $632.5 million convertible bond issuance, call spread purchase, and repurchase of outstanding convertible notes

December 2019:  JWCA acts as exchange agent for Ionis Pharmaceuticals on its $549 million convertible bond exchange, new issuance and call spread purchase

December 2016:  JWCA acts as exchange agent for Ionis Pharmaceuticals on an exchange of its 2.75% Convertible Notes due 2019 into its existing Convertible Notes due 2021

November 2014:  JWCA advises Ionis Pharmaceuticals on its $500 million Convertible bond offering